|
Cutaneous endothelial tumors
|
Location within the skin a
|
Actinic changes b
|
Tumor size c
|
|---|
|
Number of tumors/total tumors (percentage)
|
P value
|
Number of tumors/total tumors (percentage)
|
P value
|
Number of tumors/total tumors (percentage)
|
P value
|
|---|
|
Dermal
|
Hypodermal
|
No
|
Yes
|
≤5 cm
|
> 5 cm
|
|---|
|
Histological diagnosisd
| | |
.008
| | |
.001
| | |
.491
|
|
Hemangioma
|
0/13 (0%)
|
13/13 (100%)
| |
11/12 (91.67%)
|
1/12 (8.33%)
| |
10/11 (90.91%)
|
1/11 (9.09%)
| |
|
Hemangiosarcoma
|
10/25 (40.0%)
|
15/25 (60.0%)
|
0/17 (0%)
|
17/17 (100%)
| |
20/24 (83.33%)
|
4/24 (16.67%)
|
|
Histological differentiation scoringd
| | |
.667
| | |
–
| | |
1.000
|
|
Well-differentiated
|
4/8 (50.0%)
|
4/8 (50.0%)
| |
0/6 (0%)
|
6/6 (100%)
| |
8/9 (88.89%)
|
1/9 (11.11%)
| |
|
Moderately differentiated
|
6/17 (35.29%)
|
11/17 (64.71%)
|
0/11 (0%)
|
11/11 (100%)
| |
12/15 (80.0%)
|
3/15 (20.0%)
|
- Non-included in inferential statistical study the poorly differentiated hemangiosarcoma (case No. 40)
- a Unavailable data in 1 hemangiosarcoma (case No. 22)
- b Unavailable data in 1 hemangioma (case No. 2) and 9 hemangiosarcomas (cases Nos. 14, 16, 17, 24, 28, 31, 32, 36, and 37)
- c Unavailable data in 2 hemangiomas (cases Nos. 6 and 7) and 2 hemangiosarcomas (cases Nos. 28 and 29)
- d Fisher’s exact test
